Aurobindo Pharma

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries. The company has 25 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. The company’s robust product portfolio is spread over 7 major therapeutic/product areas encompassing CNS, Antiretroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic, supported by a strong R&D set-up.

Registered Company Name	Arbindo Pharma Limited
Active/Inactive	Active
CIN	L24239TG1986PLC015190
Email	info@aurobindo.com
Headquater	Hyderabad, Telangana, India
Office Location	Hyderabad, Telangana, India
Incorporation Year	1986(38 yrs old)
Industry	Pharmaceuticals
Company Employees	10000+
Website	http://aurobindo.com
Avg Revenue	$ 1 - 10B
Phone Number	+91 (40) 6672 1200
Social Profile